Triamcinolone Acetonide Suprachoroidal Injectable Suspension(Arctic Vision)

曲安奈德脉络膜上腔注射混悬液（极目生物）

Report date: 2025/11/14 14:16:42

Base Information

Drug NameTriamcinolone Acetonide Suprachoroidal Injectable Suspension(Arctic Vision)
Drug Alias NameTriamcinolono acetonidas曲安奈德缓释制剂Triamcinoloni acetonidumTriamcynolonu acetonidTriamsinolon Asetonid +[15] 
ClassificationSmall molecules > Steroids
Mechanisms of ActionGlucocorticoid receptor agonists
TargetsGlucocorticoid receptor
Therapy Area/IndicationsDiabetic macular oedemaUveitis, IntermediateUveitis, Posterior +[8] 
Global Approved IndicationsUveitisMacular Edema
Approved Indications in ChinaN/A
Original Approved Country/TerritoryUnited States
Original Approved Date2021/10/22
Country/TerritoryCanadaUnited StatesSlovakia +[17] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaNDA/BLA
Originator CompaniesClearside Biomedical Inc
China Registration ClassN/A

Develop Information

Active CompaniesAlcami Carolinas CorporationArctic Vision Singapore Pte LtdNitto Avecia Pharma Services Inc +[6] 
Inactive CompaniesClearside Biomedical Inc
Active IndicationsDiabetic macular oedemaUveitisMacular Edema
Inactive IndicationsUveitis, IntermediateUveitis, PosteriorUveitis, Anterior +[5] 

Other Information

ATC CodeN/A
Related LinksWikipediaDrugBankKEGG